Insider Buys
This tool is in beta, validation in progress.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Risk Factors Update Summary
- A prolonged downturn in macroeconomic conditions may materially adversely affect our business. This change might result in significant reductions in sales and cash flows.
- We recorded a non-cash impairment charge of $111.3 million within "Impairment of goodwill and intangible assets" in our financial statements.
- The BIOSECURE Act could impact our supply chain, requiring changes in manufacturers, potentially delaying product development.
- We identified a material weakness in our internal control over financial reporting as of September 30, 2024, which could lead to significant remediation costs.
- Our stock price fluctuated between a high of $124.67 and a low of $36.51 per share during fiscal year 2024, indicating volatility risks.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=933974&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.